Healthcare Market Research Insights for Life Sciences Firms
The fast paced nature of life sciences markets is affected by new modalities, tightening of evidence benchmarks, and ever present pricing pressures that can change launch plans in a matter of months. Healthcare Market Research aids life sciences companies in avoiding market entry assumptions, enabling teams to accurately target priorities, segments, messages, and evidence prior to heavy financial commitments.

What insights deliver
More accurate demand forecasting
Research identifies the predictors of first adoption
(patients, HCPs, payers, or employers), the “job to be done” that your
therapy/device fills, and the most important unmet needs in the US.
It aids in forecasting by blending qualitative factors (the
reasons people choose) with quantitative measures (the number of people that
choose).
Enhanced evidence and claims strategy
Legitimate consumer health and life sciences brands are
under more scrutiny to provide support for claims, and therefore, to be more
compliant, providing evidence, especially real world evidence (RWE) and
empirical based surveys as opposed to opinion surveys.
More and more, real world evidence (RWE) and real world data
(RWD) are used throughout the product life cycle for trial design, post market
surveillance, and market access.
Essential services for life sciences industries
Customized primary research with relevant stakeholders.
The most effective programs include comprehensive surveys
and deep interviews with US healthcare market research providers,
and payers/access stakeholders that include patients and caregivers (when
relevant) to identify and understand the adoption barriers and decision levers.
The studies assist the multiple functions of positioning,
patient pathways, and channel strategy, using evidence, not guesswork.
Segmentation, pricing, and message testing
Segmentation elucidates what specialties, care settings, and
subgroup of patients is most viable for entry into commercialization.
Message testing and pricing research provide value stories
aligned to what buyers will approve and reimburse, reducing the risk of
launching.
Why it matters now
The complexity of life sciences leaders has added AI-driven
shifts and global uncertainty for 2026; resilience, and more rapid decision-making,
become more critical.
The pressure on the industry to achieve greater efficiency
in R&D and commercialization is also even greater, emphasizing how early
market inputs can streamline the process and lessen disruptive adjustments.
Future trends to watch
An increase in AI-driven research operations
The rapid increase of AI in research will result in faster
and more efficient data synthesis and pattern recognition.
More market access and trust through RWE
Increasing rwe helps to answer questions around compliance,
and helps to monitor safety and effectiveness in the post-launch phase,
especially in areas of high unmet need.It brings even more value to finding the
most suitable research partner and designing a study than just “collecting
feedback.”
Collaborate with Tendance Research
Tendance Research
works across industries, providing full-service market research, including
Healthcare Market Research, market quantitative research, B2B research, and consumer research
on a global scale to aid strategic decisions.
If your team is planning to launch, expand, or reposition in
the US, partner with Tendance Research to create a tailored research plan that
validates demand, refines messaging, and fosters growth through conclusive and
strategic support.
Comments
Post a Comment